Maximum Cap Amount. The total aggregated payments made by RedHill pursuant to this Agreement, including, without limitation, the upfront payment, milestone payments and Royalties, shall not exceed a maximum cap amount of US $30 million (the “Cap Amount”). If the Cap Amount is reached, no additional payment of any kind whatsoever shall be due.
Appears in 2 contracts
Sources: Exclusive License Agreement (RedHill Biopharma Ltd.), Exclusive License Agreement (SCOLR Pharma, Inc.)